✉news CultureBooks first seen 3 d ago, last 3 d ago, peak #37
PDE9 Heart Failure Drug Disappoints in Phase II Trials
Original: Novel PDE9 Drug Stumbles in Phase II Heart Failure Trials
An experimental PDE9 inhibitor designed to treat heart failure has produced disappointing results in Phase II clinical trials, according to Medscape reporting. The setback raises questions about the drug's future development and its prospects for patients with the condition, who currently have limited treatment options beyond existing therapies.
Why now: Clinical trial failures of a novel cardiovascular drug draw attention from clinicians, researchers, and investors monitoring the heart failure treatment pipeline.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2861723